Literature DB >> 17853471

PAK3 related mental disability: further characterization of the phenotype.

Maarit Peippo1, Anne M Koivisto, Teppo Särkämö, Marjatta Sipponen, Harriet von Koskull, Tero Ylisaukko-oja, Karola Rehnström, Guy Froyen, Jaakko Ignatius, Irma Järvelä.   

Abstract

We report clinical, neuropsychological and molecular findings in affected males and carrier females in the fourth reported family with mental retardation caused by mutation in the PAK3 gene (Xq22.3-q23), W446S. In contrast to previous reports, carrier females manifested learning problems and mild mental disability. Skewed X-inactivation was observed here for the first time in carriers of PAK3 mutation. Neuropsychological tests in affected males and carrier females suggested a common neuropsychological profile of impaired spatial cognitive abilities and defects in attentional and executive functions. The five affected males examined herein had a proportionally small head size or microcephaly, large ears, oral motor hypotonia with drooling and inarticulate speech and short attention span, anxiety, restlessness, and aggression. Brain imaging showed signs of chronic non-progressive hydrocephalus in one patient who manifested psychosis and fluctuant gait deterioration, while two other patients showed no abnormalities. EEG recordings were available from four affected males and one carrier female, and all showed similar posterior slow wave activity without epileptic discharges. Only one affected male in the family suffered from epilepsy. When comparing the affected males in this family and the three previously reported families with mental retardation due to a PAK3 mutation, similarities in their characteristics were small head size or microcephaly, large ears, speech defects, behavioral abnormalities, and psychiatric disease. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17853471     DOI: 10.1002/ajmg.a.31956

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  20 in total

1.  Getting smart about p21-activated kinases.

Authors:  Mollie L Kelly; Jonathan Chernoff
Journal:  Mol Cell Biol       Date:  2010-11-29       Impact factor: 4.272

2.  Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment.

Authors:  Eric M Morrow; Anna Kane; Donald C Goff; Christopher A Walsh
Journal:  Schizophr Res       Date:  2008-09-20       Impact factor: 4.939

3.  p21-Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties.

Authors:  Wayne Huang; Zikai Zhou; Suhail Asrar; Mark Henkelman; Wei Xie; Zhengping Jia
Journal:  Mol Cell Biol       Date:  2010-11-29       Impact factor: 4.272

Review 4.  Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how.

Authors:  Yan Wang; Fuzheng Guo
Journal:  Biol Rev Camb Philos Soc       Date:  2021-11-22

Review 5.  Chromosome abnormalities, mental retardation and the search for genes in bipolar disorder and schizophrenia.

Authors:  D H R Blackwood; T Thiagarajah; P Malloy; B S Pickard; W J Muir
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  Array-CGH in unclear syndromic nephropathies identifies a microdeletion in Xq22.3-q23.

Authors:  Alexander Hoischen; Christina Landwehr; Sarah Kabisch; Xiao-Qi Ding; Detlef Trost; Gerhard Stropahl; Marianne Wigger; Bernhard Radlwimmer; Ruthild G Weber; Dieter Haffner
Journal:  Pediatr Nephrol       Date:  2009-05-15       Impact factor: 3.714

Review 7.  The mammalian family of sterile 20p-like protein kinases.

Authors:  Eric Delpire
Journal:  Pflugers Arch       Date:  2009-04-28       Impact factor: 3.657

Review 8.  Remarkable reductions of PAKs in the brain tissues of scrapie-infected rodent possibly linked closely with neuron loss.

Authors:  Ge Meng; Chan Tian; Hui Wang; Yin Xu; Bao-Yun Zhang; Qi Shi; Chen Gao; Cao Chen; Xue-Yu Fan; Jing Wang; Kang Xiao; Ke Ren; Ming-Ming Xue; Xiao-Ping Dong
Journal:  Med Microbiol Immunol       Date:  2014-05-29       Impact factor: 3.402

9.  Shared Neurodevelopmental Perturbations Can Lead to Intellectual Disability in Individuals with Distinct Rare Chromosome Duplications.

Authors:  Thiago Corrêa; Cíntia B Santos-Rebouças; Maytza Mayndra; Albert Schinzel; Mariluce Riegel
Journal:  Genes (Basel)       Date:  2021-04-23       Impact factor: 4.096

10.  Characterization of X-linked SNP genotypic variation in globally distributed human populations.

Authors:  Amanda M Casto; Jun Z Li; Devin Absher; Richard Myers; Sohini Ramachandran; Marcus W Feldman
Journal:  Genome Biol       Date:  2010-01-28       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.